Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Research on cancer vaccines reported by scientists at University of Iowa, Department of Urology
April 9th, 2008
Current study results from the report, 'The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity,' have been published. According to recent research published in the journal Cancer Immunology, Immunotherapy, "The receptor responsible for the attachment of bacillus Calmette-Guerin (BCG) to fibronectin, fibronectin attachment protein (FAP), has been cloned. Studies targeting FAP as an inducer of immunity in mycobacterial infections suggest that FAP is a highly immunogenic protein." "In light of these findings and the need to find effective alternatives to BCG treatment for bladder cancer, we tested the ability of FAP to...
Source: Vaccine Weekly (2008-04-09)
|
